Outset Tablo Could Boost Use of Home Hemodialysis
In data from a survey of 202 dialysis patients presented at the NKF Spring Clinicals meeting in Boston, MA, 77% said the features of the Tablo would make them more likely to try home HD. In addition, 77% of 184 nephrologist agreed that the Tablo features were “a significant improvement”—and 98% said they would be more likely to recommend home HD to their patients.
Read the full article » | Posted 05-12-2022
- Baxter Showcases Kidney Care Products Posted 06-10-2022
- DaVita and Medtronic to Launch New Kidney Tech Company Posted 06-10-2022
- Outset Medical Presents Three New Datasets at NKF Spring Clinicals Posted 04-18-2022
- Davita Appoints New Chair of Home Therapies Posted 03-16-2022